China Universal Asset Management Co., Ltd. Evelo Biosciences, Inc. Transaction History

China Universal Asset Management Co., Ltd.

  • $893 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 21, 2024
BUY
$0.17 - $1.57 $63 - $585
373 Added 33.51%
1,486 $0
Q1 2023

Apr 27, 2023
BUY
$0.17 - $1.57 $63 - $585
373 Added 33.51%
1,486 $0
Q4 2022

May 21, 2024
BUY
$1.44 - $48.2 $1,602 - $53,646
1,113 New
1,113 $1,000
Q4 2022

Jan 31, 2023
BUY
$1.44 - $48.2 $146 - $4,916
102 Added 10.09%
1,113 $2,000
Q3 2022

Oct 21, 2022
BUY
$1.86 - $41.8 $1,880 - $42,259
1,011 New
1,011 $2,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email